ARK5 promotes doxorubicin resistance in hepatocellular carcinoma via epithelial-mesenchymal transition.
Xu T, Zhang J, Chen W, Pan S, Zhi X, Wen L, Zhou Y, Chen BW, Qiu J, Zhang Y, Yang Q, Feng X, Bai X, Liang T.
Xu T, et al. Among authors: zhou y.
Cancer Lett. 2016 Jul 28;377(2):140-8. doi: 10.1016/j.canlet.2016.04.026. Epub 2016 Apr 25.
Cancer Lett. 2016.
PMID: 27126361